Key message 2
Delayed response to viral rebound puts individuals and society at risk
When treatment failure is detected, clinical action in response to this is delayed. In the absence of tools to detect ongoing non-adherence or drug resistance, clinicians tend to keep patients on a failing treatment regimen. As a result, it takes more than a year for patients with virological failure and an infectious viral load to be given new and appropriate treatment.
About ITREMA
The ITREMA project is funded bij ZonMw and supported by the African HIV Care & Cure (AHC²) Foundation and the Aidsfonds. ITREMA is a collaboration between investigators from the University Medical Center Utrecht (UMCU), Utrecht University, Radboud University Medical Center Nijmegen, the University of the Witwatersrand (Johannesburg, South Africa) and Ndlovu Care Group (NCG, Limpopo, South Africa).
Get in contact with us
ITREMA
Heidelberglaan 100
3584 CX Utrecht, The Netherlands
Location
University Medical Centre Utrecht, Department of Medical Microbiology
+31 88 75 565 26
f.bikhezar@umcutrecht.nl
